Alterations in Rat Accumbens Dopamine, Endocannabinoids and GABA Content During WIN55,212-2 Treatment: The Role of Ghrelin

Overview

Journal Int J Mol Sci

Publisher MDPI

Specialties Biochemistry
Chemistry
Molecular Biology

Date 2020 Dec 31

PMID 33379212

Citations 9

Authors

Chrysostomos Charalambous

Marek Lapka

Tereza Havlickova

Kamila Syslova

Magdalena Sustkova-Fiserova

Affiliations

Soon will be listed here.

Abstract

The endocannabinoid/CB1R system as well as the central ghrelin signalling with its growth hormone secretagogoue receptors (GHS-R1A) are importantly involved in food intake and reward/reinforcement processing and show distinct overlaps in distribution within the relevant brain regions including the hypothalamus (food intake), the ventral tegmental area (VTA) and the nucleus accumbens (NAC) (reward/reinforcement). The significant mutual interaction between these systems in food intake has been documented; however, the possible role of ghrelin/GHS-R1A in the cannabinoid reinforcement effects and addiction remain unclear. Therefore, the principal aim of the present study was to investigate whether pretreatment with GHS-R1A antagonist/JMV2959 could reduce the CB1R agonist/WIN55,212-2-induced dopamine efflux in the nucleus accumbens shell (NACSh), which is considered a crucial trigger impulse of the addiction process. The synthetic aminoalklylindol cannabinoid WIN55,212-2 administration into the posterior VTA induced significant accumbens dopamine release, which was significantly reduced by the 3 mg/kg i.p. JMV2959 pretreatment. Simultaneously, the cannabinoid-increased accumbens dopamine metabolic turnover was significantly augmented by the JMV2959 pretreament. The intracerebral WIN55,212-2 administration also increased the endocannabinoid arachidonoylethanolamide/anandamide and the 2-arachidonoylglycerol/2-AG extracellular levels in the NACSh, which was moderately but significantly attenuated by the JMV2959 pretreatment. Moreover, the cannabinoid-induced decrease in accumbens γ-aminobutyric acid/gamma-aminobutyric acid levels was reversed by the JMV2959 pretreatment. The behavioural study in the LABORAS cage showed that 3 mg/kg JMV2959 pretreatment also significantly reduced the systemic WIN55,212-2-induced behavioural stimulation. Our results demonstrate that the ghrelin/GHS-R1A system significantly participates in the rewarding/reinforcing effects of the cannabinoid/CB1 agonist that are involved in cannabinoid addiction processing.

Citing Articles

Diverse Underlying Mechanisms and Sex Differences Found in Translational Models of Cannabinoids Use: Towards Validation in Human Studies.

Ferber S, Weller A Int J Mol Sci. 2023; 24(23).

PMID: 38068909 PMC: 10706558. DOI: 10.3390/ijms242316586.

Metabolic hormone action in the VTA: Reward-directed behavior and mechanistic insights.

Geisler C, Hayes M Physiol Behav. 2023; 268:114236.

PMID: 37178855 PMC: 10330780. DOI: 10.1016/j.physbeh.2023.114236.

Animal studies reveal that the ghrelin pathway regulates alcohol-mediated responses.

Jerlhag E Front Psychiatry. 2023; 14:1050973.

PMID: 36970276 PMC: 10030715. DOI: 10.3389/fpsyt.2023.1050973.

Impaired Ghrelin Signaling Does Not Lead to Alterations of Anxiety-like Behaviors in Adult Mice Chronically Exposed to THC during Adolescence.

Sestan-Pesa M, Shanabrough M, Horvath T, Miletta M Biomedicines. 2023; 11(1).

PMID: 36672651 PMC: 9855766. DOI: 10.3390/biomedicines11010144.

Mepirapim, a Novel Synthetic Cannabinoid, Induces Addiction-Related Behaviors through Neurochemical Maladaptation in the Brain of Rodents.

Hur K, Lee Y, Donio A, Ma S, Lee B, Kim S Pharmaceuticals (Basel). 2022; 15(6).

PMID: 35745629 PMC: 9229951. DOI: 10.3390/ph15060710.

References

Skibicka K, Hansson C, Alvarez-Crespo M, Friberg P, Dickson S . Ghrelin directly targets the ventral tegmental area to increase food motivation. Neuroscience. 2011; 180:129-37. DOI: 10.1016/j.neuroscience.2011.02.016. View

Compton D, GOLD L, Ward S, Balster R, Martin B . Aminoalkylindole analogs: cannabimimetic activity of a class of compounds structurally distinct from delta 9-tetrahydrocannabinol. J Pharmacol Exp Ther. 1992; 263(3):1118-26. View

Nestler E . Is there a common molecular pathway for addiction?. Nat Neurosci. 2005; 8(11):1445-9. DOI: 10.1038/nn1578. View

Sustkova-Fiserova M, Puskina N, Havlickova T, Lapka M, Syslova K, Pohorala V . Ghrelin receptor antagonism of fentanyl-induced conditioned place preference, intravenous self-administration, and dopamine release in the nucleus accumbens in rats. Addict Biol. 2019; 25(6):e12845. DOI: 10.1111/adb.12845. View

Jerlhag E, Egecioglu E, Landgren S, Salome N, Heilig M, Moechars D . Requirement of central ghrelin signaling for alcohol reward. Proc Natl Acad Sci U S A. 2009; 106(27):11318-23. PMC: 2703665. DOI: 10.1073/pnas.0812809106. View

Jiang H, Betancourt L, Smith R . Ghrelin amplifies dopamine signaling by cross talk involving formation of growth hormone secretagogue receptor/dopamine receptor subtype 1 heterodimers. Mol Endocrinol. 2006; 20(8):1772-85. DOI: 10.1210/me.2005-0084. View

Serrenho D, Santos S, Carvalho A . The Role of Ghrelin in Regulating Synaptic Function and Plasticity of Feeding-Associated Circuits. Front Cell Neurosci. 2019; 13:205. PMC: 6546032. DOI: 10.3389/fncel.2019.00205. View

Jerlhag E, Egecioglu E, Dickson S, Andersson M, Svensson L, Engel J . Ghrelin stimulates locomotor activity and accumbal dopamine-overflow via central cholinergic systems in mice: implications for its involvement in brain reward. Addict Biol. 2006; 11(1):45-54. DOI: 10.1111/j.1369-1600.2006.00002.x. View

Sustkova-Fiserova M, Jerabek P, Havlickova T, Kacer P, Krsiak M . Ghrelin receptor antagonism of morphine-induced accumbens dopamine release and behavioral stimulation in rats. Psychopharmacology (Berl). 2014; 231(14):2899-908. DOI: 10.1007/s00213-014-3466-9. View

10.

Polissidis A, Chouliara O, Galanopoulos A, Rentesi G, Dosi M, Hyphantis T . Individual differences in the effects of cannabinoids on motor activity, dopaminergic activity and DARPP-32 phosphorylation in distinct regions of the brain. Int J Neuropsychopharmacol. 2009; 13(9):1175-91. DOI: 10.1017/S1461145709991003. View

11.

Sustkova-Fiserova M, Jerabek P, Havlickova T, Syslova K, Kacer P . Ghrelin and endocannabinoids participation in morphine-induced effects in the rat nucleus accumbens. Psychopharmacology (Berl). 2015; 233(3):469-84. DOI: 10.1007/s00213-015-4119-3. View

12.

Jerlhag E, Egecioglu E, Dickson S, Douhan A, Svensson L, Engel J . Ghrelin administration into tegmental areas stimulates locomotor activity and increases extracellular concentration of dopamine in the nucleus accumbens. Addict Biol. 2007; 12(1):6-16. DOI: 10.1111/j.1369-1600.2006.00041.x. View

13.

Castaneda T, Tong J, Datta R, Culler M, Tschop M . Ghrelin in the regulation of body weight and metabolism. Front Neuroendocrinol. 2009; 31(1):44-60. DOI: 10.1016/j.yfrne.2009.10.008. View

14.

Lupica C, Riegel A, Hoffman A . Marijuana and cannabinoid regulation of brain reward circuits. Br J Pharmacol. 2004; 143(2):227-34. PMC: 1575338. DOI: 10.1038/sj.bjp.0705931. View

15.

Polissidis A, Chouliara O, Galanopoulos A, Marselos M, Papadopoulou-Daifoti Z, Antoniou K . Behavioural and dopaminergic alterations induced by a low dose of WIN 55,212-2 in a conditioned place preference procedure. Life Sci. 2009; 85(5-6):248-54. DOI: 10.1016/j.lfs.2009.05.015. View

16.

Panlilio L, Justinova Z, Goldberg S . Inhibition of FAAH and activation of PPAR: new approaches to the treatment of cognitive dysfunction and drug addiction. Pharmacol Ther. 2013; 138(1):84-102. PMC: 3662489. DOI: 10.1016/j.pharmthera.2013.01.003. View

17.

Aono Y, Saigusa T, Mizoguchi N, Iwakami T, Takada K, Gionhaku N . Role of GABAA receptors in the endomorphin-1-, but not endomorphin-2-, induced dopamine efflux in the nucleus accumbens of freely moving rats. Eur J Pharmacol. 2007; 580(1-2):87-94. DOI: 10.1016/j.ejphar.2007.10.020. View

18.

Saigusa T, Aono Y, Mizoguchi N, Iwakami T, Takada K, Oi Y . Role of GABA B receptors in the endomorphin-1-, but not endomorphin-2-, induced dopamine efflux in the nucleus accumbens of freely moving rats. Eur J Pharmacol. 2008; 581(3):276-82. DOI: 10.1016/j.ejphar.2007.12.008. View

19.

DAmbra T, Estep K, Bell M, Eissenstat M, Josef K, Ward S . Conformationally restrained analogues of pravadoline: nanomolar potent, enantioselective, (aminoalkyl)indole agonists of the cannabinoid receptor. J Med Chem. 1992; 35(1):124-35. DOI: 10.1021/jm00079a016. View

20.

Chen J, PAREDES W, Lowinson J, Gardner E . Strain-specific facilitation of dopamine efflux by delta 9-tetrahydrocannabinol in the nucleus accumbens of rat: an in vivo microdialysis study. Neurosci Lett. 1991; 129(1):136-80. DOI: 10.1016/0304-3940(91)90739-g. View